Icon

EVDI - (1MG/20ML (0.05MG/ML); SOLUTION)

TRABECTEDIN None
1MG/20ML (0.05MG/ML); SOLUTION
Less Than $1000 mn
None None
None None
None None
EVDI is an alkylating drug indicated for the treatment of adult patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen.
Yes

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.